Paragraf Is Finding A Way To Bring Graphene To Diagnostics
The UK-based company is creating a range of diagnostic sensors built using graphene, allowing for faster, more sensitive testing products.
You may also be interested in...
Approved in Europe and just given the US green light, MeMed is making waves in the fight against antimicrobial resistance using advanced "host response" technology. Its CEO talks to In Vivo about strategy, commercialization and earning the right to fantasize.
The company is trialing absorbable implants for both cosmetic and reconstructive surgeries.
In this edition of Medtech Monthly, Robert Gabbay, chief scientific and medical officer for the American Diabetes Association talked to Medtech Insight about diabetes tech, where it's headed, and what it could mean for preventative care.